November 21, 2026

New data suggest J&J vaccine works against Delta

A single dose of the COVID-19 vaccine made by Johnson & Johnson is highly effective in preventing severe illness and death from the Delta and beta variants of the coronavirus, data from a clinical trial in South Africa suggest.

The New York Times

>> Apoorva Mandavilli

The New York Times

Published : 07 Aug 2021, 10:06 AM

Updated : 08 Apr 2022, 01:07 PM

The study is the first real-world test of the vaccine’s efficacy against Delta, a highly contagious variant of the virus surging across the United States and much of the world. South Africa’s Ministry of Health reported these preliminary results at a news conference Friday. The data have not yet been peer-reviewed or published in a scientific journal.

In the trial, called Sisonke, the researchers evaluated one dose of the Johnson & Johnson vaccine in nearly 500,000 health care workers, who are at high risk of COVID-19. The vaccine has an efficacy of up to 95 percent against death from the Delta variant, and up to 71 percent against hospitalization, the researchers reported. (The vaccine did slightly worse against the beta variant, which is thought to be more adept at sidestepping the immune response than Delta.)

“We believe this vaccine is doing what it was designed to do, which was to stop people going to hospital and stop them ending in ICUs and dying,” said Dr Linda-Gail Bekker, co-lead of the study and director of the Desmond Tutu HIV Centre at the University of Cape Town.

The results suggest that people who have received one dose of the Johnson & Johnson vaccine don’t need a booster shot, Bekker said.

When so-called breakthrough infections did occur in vaccinated volunteers, they produced mild symptoms in 96 percent of the cases and resulted in severe disease or death in less than 0.05 percent, the study found. The trial ran from February to May of this year.

The results should comfort the millions of people who have received the J & J vaccine, particularly because some previous studies had suggested the single shot may be vulnerable to Delta.

© 2021 The New York Times Company

Related Stories